ozari healths new telehealth platform for compounded glp-1s
Posted by devin280 in Research & News - 0 points, 0 comments.
this article is about ozari health launching a nationwide telehealth platform for compounded semaglutide and tirzepatide starting at $86 a month. honestly, the price point is what jumps out to me first, because once you add in consults, follow-up, and the usual fine print, the real monthly cost can look a bit less shiok than the headline. from my side, i think the convenience of telehealth is real, especially for people who cant easily get to a clinic, but compounded products always make me cautious because quality, consistency, and patient screening matter a lot.
in singapore terms, cheap is nice, but cheap and rushed is usually where the trouble starts. i would want to know how they handle monitoring, side effects, and whether patients are properly assessed before getting a prescription. what do you all think, is this kind of platform actually making access better, or just repackaging a very crowded market?
Community discussion - research and educational context only. Not medical advice.